Subtype
Benign Vascular Neoplasm
CI-CAN-00000556Explore in graph →
Non-malignant13 active trials1 evidence items
- NCIt
- C7389
Loading cancer entity…
Subtype
CI-CAN-00000556Explore in graph →
Clinical trials
97 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00975819 | Safety and Efficacy Study of Sirolimus in Complicated Vascular Anomalies | completed | Phase 2 | 61 | Denise Martin AdamsOTHER | 1 | Jan 6, 2026 | clinicaltrials |
| NCT05050149 | Study Evaluating the Safety and Efficacy of PTX-022 (QTORIN Sirolimus) in the Treatment of Microcystic Lymphatic Malformations | completed | Phase 2 | 12 | Palvella Therapeutics, Inc.INDUSTRY | 1 | Jan 17, 2025 | clinicaltrials |
| NCT06677853 |
| Timolol Maleate Gel for the Treatment of Infantile Hemangioma |
| completed |
| Phase 2 / Phase 3 |
| 168 |
| Auson Pharmaceuticals Inc.INDUSTRY |
| 1 |
| Nov 7, 2024 |
| clinicaltrials |
| NCT02913612 | Efficacy, Safety and Pharmacokinetics of Topical Timolol in Infants With Infantile Hemangioma (IH)(TIM01) | completed | Phase 2 | 105 | Kanecia Obie ZimmermanOTHER | 1 | Mar 12, 2024 | clinicaltrials |
| NCT03188068 | Sirolimus Versus Sirolimus Plus Prednisolone for Kaposiform Hemangioendothelioma | completed | Phase 2 | 30 | West China HospitalOTHER | 1 | Apr 21, 2022 | clinicaltrials |
| NCT01010308 | Nadolol for Proliferating Infantile Hemangiomas | completed | Phase 2 | 20 | The Hospital for Sick ChildrenOTHER | 1 | Aug 19, 2021 | clinicaltrials |
| NCT02731287 | Topical Timolol for Infantile Hemangioma in Early Proliferative Phase | completed | Phase 2 | 70 | Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant PauOTHER | 1 | Nov 14, 2018 | clinicaltrials |
| NCT02145884 | Topical Timolol Gel for the Treatment of Infantile Hemangiomas | completed | Phase 2 | 26 | Rady Children's Hospital, San DiegoOTHER | 1 | Feb 13, 2017 | clinicaltrials |
| NCT01056341 | Study to Demonstrate the Efficacy and Safety of Propranolol Oral Solution in Infants With Proliferating Infantile Hemangiomas Requiring Systemic Therapy | completed | Phase 2 / Phase 3 | 512 | Pierre Fabre DermatologyINDUSTRY | 16 | Dec 10, 2015 | clinicaltrials |
| NCT01290484 | A Study to Evaluate Sildenafil for the Treatment of Lymphatic Malformations | completed | Phase 1 / Phase 2 | 7 | Stanford UniversityOTHER | 1 | Jun 19, 2015 | clinicaltrials |
| NCT01072045 | Comparative Study of the Use of Beta Blocker and Oral Corticosteroid in the Treatment of Infantile Hemangioma | completed | Phase 2 | 50 | University of Sao PauloOTHER | 1 | Dec 2, 2014 | clinicaltrials |
| NCT01512173 | Study in Infants With Infantile Hemangioma to Compare Propranolol Gel to Placebo | completed | Phase 2 | 82 | Pierre Fabre DermatologyINDUSTRY | 3 | Oct 30, 2014 | clinicaltrials |
| NCT00601016 | A Phase II Study of Imiquimod 5 % Cream for the Treatment of Hemangioma in Infancy | completed | Phase 2 | 18 | St. Justine's HospitalOTHER | 1 | Jan 25, 2008 | clinicaltrials |
Data updated 22 days agoSource updated Jan 6, 2026source: clinicaltrials